The clinical team will not be blinded to group allocation as propofol, the most commonly used sedative, has a distinctive white appearance, which renders blinding unfeasible. Study participants will effectively be blinded, as the intervention will be initiated when the participant is still intubated and emerging from anaesthesia. Once weaned from mechanical ventilation, propofol is discontinued; however, DEX, a clear solution, will be one of a number of infusions, and it will be difficult for participants to distinguish/identify specific medications. Data collectors and those administering postoperative cognitive tests will be blinded and will not be able to ascertain group allocation during follow-up visits as they occur after discontinuation of the intervention.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.